Publication | Open Access

Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody

Week 6MedicineImmunologyBronchial NeoplasmImmune Checkpoint InhibitorPost-treatment Neutrophil-to-lymphocyte RatioAnti-pd-1 AntibodyImmunotherapyOncologyRadiation OncologyLung Cancer